What does this video actually claim?
Bruna Cavalcante's TikTok shows her transformation while using tirzepatide (Mounjaro), with the caption "basics that work." The video focuses on weight loss results from the GLP-1 medication combined with what appears to be lifestyle changes.
The hashtags suggest she's promoting tirzepatide alongside training and discipline. While she doesn't make explicit medical claims in the caption, the before-and-after format implies the medication was effective for weight management. The "basics" framing suggests this approach is straightforward.
However, the video lacks specifics about dosing, timeline, or side effects. It's essentially a visual testimonial rather than educational content about how tirzepatide works.
Does tirzepatide actually deliver these results?
Yes, the clinical data supports significant weight loss with tirzepatide. The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) found 22.5% body weight reduction at the highest 15mg dose over 72 weeks in adults without diabetes.
That's substantially higher than semaglutide's results. The STEP 1 trial with semaglutide 2.4mg achieved 14.9% weight loss over 68 weeks. Tirzepatide targets both GLP-1 and GIP receptors, which may explain the enhanced efficacy.
The medication works by slowing gastric emptying and reducing appetite through central nervous system pathways. Most participants in SURMOUNT-1 lost at least 5% of their body weight, with 57% losing 20% or more at the highest dose.
What's missing from this TikTok?
Cavalcante doesn't mention side effects, which affect most users. In SURMOUNT-1, 81% of participants experienced gastrointestinal issues including nausea, diarrhea, and vomiting, particularly during dose escalation periods.
She also skips the cost reality. Tirzepatide runs about $1,000 monthly without insurance coverage. Many insurance plans don't cover it for weight management, only for type 2 diabetes treatment.
The "basics" framing is misleading too. Starting tirzepatide requires medical supervision, regular monitoring, and gradual dose increases from 2.5mg to potentially 15mg over months. There's nothing basic about managing a prescription medication that affects your digestive system and blood sugar.
What should you actually know about tirzepatide?
The medication isn't a quick fix despite impressive trial results. The SURMOUNT-1 participants who achieved 22.5% weight loss did so over 72 weeks, not months. Weight regain typically occurs when people stop treatment.
You'll need to start at 2.5mg weekly and increase every four weeks based on tolerance. The therapeutic doses range from 5mg to 15mg weekly. Your doctor should monitor for gallbladder problems, pancreatitis risk, and thyroid issues during treatment.
Lifestyle changes remain important even on tirzepatide. The clinical trials included dietary counseling and exercise recommendations. The medication makes it easier to eat less, but you still need to make good food choices to maintain results long-term.